Protalix BioTherapeutics, Inc. (PLX) stock is tumbling today: Why is it so?

AEYE Stock

Shares of the Protalix BioTherapeutics, Inc. (PLX)  stock were tumbling today following the release of the updated data related to the clinical development of PRX-102 for the treatment of patients suffering from Fabry Disease. PLX stock price saw a downtrend of  14.77% to drop at $2.54 a share as of this writing. At the previous […]